Please use this identifier to cite or link to this item:
https://hdl.handle.net/11499/4160
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Yaren, Arzu. | - |
dc.contributor.author | Kelten, Canan. | - |
dc.contributor.author | Akbulut, M. | - |
dc.contributor.author | Teke, Z. | - |
dc.contributor.author | Duzcan, E. | - |
dc.contributor.author | Erdem, Ergün. | - |
dc.date.accessioned | 2019-08-16T11:32:26Z | |
dc.date.available | 2019-08-16T11:32:26Z | |
dc.date.issued | 2007 | - |
dc.identifier.issn | 0300-8916 | - |
dc.identifier.uri | https://hdl.handle.net/11499/4160 | - |
dc.description.abstract | Primary neuroendocrine carcinoma of the breast is an extremely rare tumor. We present our experience of primary neuroendocrine carcinoma of the breast in a 76-year-old woman. Surgical biopsies from breast and axillary lymphadenopathy showed a neuroendocrine carcinoma. Immunohistochemical staining of tumor cells with GCDFP15, NSE and chromogranin were positive. Computed tomography scans of the chest and abdomen showed no lesion for metastasis or another primary origin. Adjuvant hormone therapy was given, since the tumor was immunohistochemically receptor positive. | en_US |
dc.language.iso | en | en_US |
dc.relation.ispartof | Tumori | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Breast neoplasm | en_US |
dc.subject | Neuroendocrine tumor | en_US |
dc.subject | chromogranin | en_US |
dc.subject | tamoxifen | en_US |
dc.subject | aged | en_US |
dc.subject | anamnesis | en_US |
dc.subject | article | en_US |
dc.subject | axillary lymph node | en_US |
dc.subject | breast biopsy | en_US |
dc.subject | breast carcinoma | en_US |
dc.subject | case report | en_US |
dc.subject | clinical feature | en_US |
dc.subject | computer assisted tomography | en_US |
dc.subject | female | en_US |
dc.subject | human | en_US |
dc.subject | immunohistochemistry | en_US |
dc.subject | lymphadenopathy | en_US |
dc.subject | mammography | en_US |
dc.subject | mastectomy | en_US |
dc.subject | neuroendocrine tumor | en_US |
dc.subject | Aged | en_US |
dc.subject | Antineoplastic Agents, Hormonal | en_US |
dc.subject | Breast Neoplasms | en_US |
dc.subject | Carcinoma, Neuroendocrine | en_US |
dc.subject | Cell Differentiation | en_US |
dc.subject | Chemotherapy, Adjuvant | en_US |
dc.subject | Female | en_US |
dc.subject | Humans | en_US |
dc.subject | Lymphatic Diseases | en_US |
dc.subject | Lymphatic Metastasis | en_US |
dc.subject | Tamoxifen | en_US |
dc.title | Primary neuroendocrine carcinoma of the breast: A case report | en_US |
dc.type | Article | en_US |
dc.identifier.volume | 93 | en_US |
dc.identifier.issue | 5 | en_US |
dc.identifier.startpage | 496 | |
dc.identifier.startpage | 496 | en_US |
dc.identifier.endpage | 498 | en_US |
dc.authorid | 0000-0001-7697-9305 | - |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.identifier.pmid | 18038885 | en_US |
dc.identifier.scopus | 2-s2.0-36749079825 | en_US |
dc.identifier.wos | WOS:000253730300016 | en_US |
dc.identifier.scopusquality | Q2 | - |
dc.owner | Pamukkale_University | - |
item.fulltext | No Fulltext | - |
item.languageiso639-1 | en | - |
item.openairetype | Article | - |
item.cerifentitytype | Publications | - |
item.grantfulltext | none | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
crisitem.author.dept | 14.02. Internal Medicine | - |
crisitem.author.dept | 14.01. Surgical Medicine | - |
Appears in Collections: | PubMed İndeksli Yayınlar Koleksiyonu / PubMed Indexed Publications Collection Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection Tıp Fakültesi Koleksiyonu WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection |
CORE Recommender
SCOPUSTM
Citations
8
checked on Nov 16, 2024
WEB OF SCIENCETM
Citations
11
checked on Nov 14, 2024
Page view(s)
34
checked on Aug 24, 2024
Google ScholarTM
Check
Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.